Key result
A prognostic model incorporating SPPB, hypertension, rehabilitation, and ACEI/ARB/ARNI medications predicted all-cause mortality in acute heart failure patients with a C-index of 0.748.
Why the study?
The SPPB test provides an assessment of rehabilitation and predicts clinical outcomes, motivating the establishment of an SPPB-based prognostic model for patients with AHF.
Does the Short Physical Performance Battery (SPPB) predict all-cause mortality in elderly patients with acute heart failure?
Cohort (n=108)
No
Does the Short Physical Performance Battery (SPPB) predict all-cause mortality in elderly patients with acute heart failure?
The Short Physical Performance Battery (SPPB) is an independent predictor of all-cause mortality in elderly patients with acute heart failure and can be incorporated into an accurate prognostic nomogram.
May aid acute HF mortality stratification via SPPB nomogram; leaves open prospective validation before clinical use.
Background The Short Physical Performance Battery (SPPB) test not only provides a precise assessment of rehabilitation but also predicts a clinical prognostic outcome. The aim was to establish a prognostic model for patients with acute heart failure (AHF) based on SPPB. Methods Patients with AHF in Tongji Hospital were screened and enrolled to conduct this retrospective cohort study. Forty‐five potential predictor variables were used in univariate and multivariate Cox regression analysis for all‐cause mortality. The prognostic model was further built with a nomogram, the accuracy of which was evaluated through the consistency index (C‐index), TimeROC curves, calibration curves, and DCA curves. Results Of 108 patients with AHF enrolled, the median follow‐up time was 454.5 days and all‐cause mortality was 53. Multivariate predictors of all‐cause mortality included SPPB, hypertension, rehabilitation, and ACEI/ARB/ARNI medications. The nomogram was developed to predict all‐cause mortality. Consistency between the predicted and actual values in the 1‐ and 2‐year survival calibration curves was excellent, with a C‐index of 0.748. TimeROC AUCs were 0.796 and 0.807 in predicting the 1‐ and 2‐year survival. The DCA curves indicated a higher net clinical benefit compared to the null model. Conclusions This study demonstrated that SPPB, hypertension, rehabilitation, and ACEI/ARB/ARNI medications were independently associated with all‐cause mortality in patients with AHF. Trial Registration: Chinese Registry of Clinical Trials: ChiCTR‐TNRC‐08000235
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2026) conducted a cohort in acute heart failure (AHF) (n=108). Short Physical Performance Battery (SPPB) based prognostic model was evaluated on all-cause mortality. A prognostic model incorporating SPPB, hypertension, rehabilitation, and ACEI/ARB/ARNI medications predicted all-cause mortality in acute heart failure patients with a C-index of 0.748.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: